North America Glucosamine Supplements Market Size & Outlook, 2026-2034
North America Glucosamine Supplements Market Insights
- Based on Deep Market Insights findings, the North America Glucosamine Supplements Market size reached USD 40.17 billion in 2025 and is expected to grow to USD 76.84 billion by 2034.
- During 2026–2034, the market is forecasted to advance at a CAGR of 7.48%.
- Capsule represented the largest share of the By Type market in terms of size in 2025.
- Among the By Type segments, Pill is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.
![North America Glucosamine Supplements Market Size, Share & Growth Analysis By [2034]](https://deepmarketinsights.com/uploads/charts/glucosamine-supplements-market-north-america--297913.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- North America held 30.06% share of the global Glucosamine Supplements Market size in 2025.
- United States is expected to remain the largest contributor to the global market size by 2034.
- By 2034, United States is anticipated to record the highest growth in North America, with the market size expected to reach USD 56.3 billion.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 40.17 billion |
| Market Size In 2034 | USD 76.84 billion |
| Largest segment | Capsule |
| Units | Revenue in USD billion |
| CAGR | 7.48% (2026-2034) |
| Segmnetation Covered | |
| North America |
|
| By Type |
|
| By Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America Glucosamine Supplements Market Country 2026-2034 (USD billion)
| North America | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | XX.x | XX.x | XX.x | 28.83 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Canada | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
North America Glucosamine Supplements Market By Type 2026-2034 (USD billion)
| By Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capsule | XX.x | XX.x | XX.x | 24.66 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pill | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
North America Glucosamine Supplements Market By Application 2026-2034 (USD billion)
| By Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | XX.x | XX.x | XX.x | 25.6 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutritional Dietary Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.